The Effect of Varenicline on Smoking Cessation in Hospitalized Patients: A Systematic Review and Meta-Analysis
Open Access
- 1 May 2024
- journal article
- review article
- Published by Maad Rayan Publishing Company in Addiction & Health
- Vol. 16 (2) , 122-129
Abstract
Background: Varenicline tartrate is a new and selective agonist of the nicotinic acetylcholine receptor (nAChR). This systematic review and meta-analysis aimed to determine varenicline efficacy in smoking cessation among hospitalized patients. Methods: We looked through worldwide databases such as Web of Science, Embase, PubMed, Cochrane, and Scopus. Relevant pieces of research published on varenicline efficacy on smoking cessation among hospitalized patients were discovered using proper keywords. The data were analyzed using Stata software version 14 and a random-effects model meta-analysis. Findings: Nine studies were eligible to be included in this study, with a total sample size of 2131. Generally, the point abstinence rate was significantly greater in the varenicline group than in the placebo group at weeks 12 (odds ratio [OR]=0.59; 95% CI: 053-0.65; P<0.001), 24 (OR=0.78; 95% CI: 0.72-0.84; P<0.001), and 52 (OR=0.86; 95% CI: 0.80-0.92; P<0.001). Furthermore, the continuous abstinence rate for weeks 4 (OR=0.70; 95% CI: 019-0.54; P=0.000), 12 (OR=0.26; 95% CI: 019-0.54; P<0.001), 24 (OR=0.32; 95% CI: 019-0.53; P<0.001), and 52 (OR=0.32; 95% CI: 019-0.54; P<0.001) was significantly greater in the varenicline group than in the placebo group. Conclusion: According to the high efficacy of varenicline in both short- and long-term smoking settings and considering the importance of smoking cessation in high-risk hospitalized patients, varenicline consumption could be considered as a main smoking cessation strategy in these patients.Keywords
This publication has 33 references indexed in Scilit:
- Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in SmokersJAMA Internal Medicine, 2018
- Utilization and effectiveness of pharmacotherapy for Tobacco use following admission for exacerbation of COPDJournal of Hospital Medicine, 2015
- Effect of Varenicline on Smoking Cessation Through Smoking ReductionJAMA, 2015
- Pharmacological interventions for smoking cessation: an overview and network meta-analysisCochrane Database of Systematic Reviews, 2013
- Nicotine replacement therapy for smoking cessationCochrane Database of Systematic Reviews, 2012
- Long-term efficacy and safety of varenicline for smoking cessation: a systematic review and meta-analysis of randomized controlled trialsJournal of Public Health, 2012
- Bupropion for Smoking Cessation in Patients With Acute Coronary SyndromeArchives of internal medicine (1960), 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Effect of Maintenance Therapy With Varenicline on Smoking CessationA Randomized Controlled TrialJAMA, 2006
- Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking CessationA Randomized Controlled TrialJAMA, 2006